Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Classificação em ações #32324
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Preço da ação
$0.88
Última sincronização: 2026-08-17
Valor de mercado
$10.41M
Variação (1 dia)
-7.26%
Variação (1 ano)
-50.56%
País
SG
Negociar CytoMed Therapeutics Limited (GDTC)

Categoria

Histórico de desdobramentos de ações de CytoMed Therapeutics Limited (GDTC)
As ações CytoMed Therapeutics Limited (símbolo: GDTC) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 18, 2026.
Uma ação GDTC comprada antes de Aug 18, 2026 equivaleria hoje a 0 ações GDTC.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR